Myoclonus associated with intraperitoneal imipenem.
Lau
Keith K
KK
Kink
Rudy J
RJ
Jones
Deborah P
DP
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001202:Ascitic Fluid / Q000382:microbiology; D002675:Child, Preschool; D016972:Enterobacter cloacae; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000009:adverse effects*; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008508:Medication Errors; D000077731:Meropenem; D009207:Myoclonus / Q000139:chemically induced*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000188:drug therapy*; D013845:Thienamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D014031:Tobramycin / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D015378:Imipenem; D000077731:Meropenem; D014031:Tobramycin